- Filed
- Feb 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Feb 12, 2025 | 85.06M sh |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $120.78M |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $132.19M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $13.13M |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $15.3M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $124.04M |
| Total Assets | Q1 2025 · Sep 30, 2024 | $135.57M |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 82.08M sh |
| Operating Cash Flow | Q1 2025 · Dec 31, 2023 | −$7.32M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $135.58M |
| Stockholders Equity | Q1 2025 · Sep 30, 2023 | $141.85M |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | −$0.11 |
| Eps Basic | Q1 2025 · Dec 31, 2023 | −$0.11 |
| Rd Expense | Q1 2025 · Dec 31, 2023 | $8.68M |
| Net Income | Q1 2025 · Dec 31, 2023 | −$8.62M |
| Operating Income restated | Q1 2025 · Dec 31, 2023 | −$11.38M |